Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-03-002697
Filing Date
2003-03-11
Accepted
2003-03-11 08:46:13
Documents
7
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 DUSA PHARMACEUTICALS, INC. y84253e10vk.txt 10-K 341638
3 COMMON STOCK SPECIMEN y84253exv4wa.txt EX-4.A 7109
4 LICENSE AND DEVELOPMENT AGREEMENT y84253exv10wr.txt EX-10.R 122354
5 SUPPLY AGREEMENT y84253exv10ws.txt EX-10.S 85995
6 INDEPENDENT AUDITORS' CONSENT OF DELOITTE & TOUCHE y84253exv23.txt EX-23 602
7 CERTIFICATION OF CEO AND CFO y84253exv99wa.txt EX-99.A 1714
8 PRESS RELEASE y84253exv99wb.txt EX-99.B 13761
  Complete submission text file 0000950123-03-002697.txt   575537
Mailing Address 25 UPTON DRIVE WILMINGTON MA 01887
Business Address 25 UPTON DRIVE WILMINGTON MA 01887 9786577500
DUSA PHARMACEUTICALS INC (Filer) CIK: 0000879993 (see all company filings)

EIN.: 223103129 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-31533 | Film No.: 03598722
SIC: 2834 Pharmaceutical Preparations